Search / Trial NCT06611982

Guaranteed Income and Financial Treatment

Launched by MEREDITH DOHERTY · Sep 20, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

Cancer-related financial hardship (i.e., financial toxicity) has been associated with anxiety and depression, greater pain and symptom burden, treatment nonadherence, and mortality. Out-of-pocket healthcare costs and lost income are primary drivers of financial toxicity, however, income loss is a pronounced risk factor for cancer patients with low incomes. There has been little progress in developing an income intervention to alleviate financial toxicity cancer patients with low incomes. Unconditional cash transfers (UCT), or guaranteed income, have produced positive health effects in exper...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age = 18 or older
  • 2. Newly diagnosed or recurrent advanced cancer (Stage 3 or 4)
  • 3. Receiving chemotherapy or immunotherapy (with or without radiation) at one of the recruitment sites
  • 4. Within 12 months of receiving systemic therapy and on surveillance at one of the recruitment sites
  • 5. ECOG performance status of 1 - 2
  • 6. A Pennsylvania Medicaid beneficiary
  • 7. A Pennsylvania resident
  • Exclusion Criteria:
  • 1. Eligible for hospice (i.e. determined by provider to have a prognosis of 6 months or less) at time of randomization
  • 2. Unable to communicate in English, Spanish, or Mandarin

About Meredith Doherty

Meredith Doherty is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodology, she leads initiatives that bridge the gap between laboratory discoveries and clinical applications. Her expertise in trial design, patient recruitment, and regulatory compliance ensures that studies are conducted ethically and efficiently. Meredith’s collaborative approach fosters partnerships with healthcare professionals, researchers, and institutions, driving the development of groundbreaking treatments that address unmet medical needs.

Locations

Philadelphia, Pennsylvania, United States

Philadelphia, Pennsylvania, United States

Philadelphia, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0